The Clorox Company

The Clorox Company (CLX) Market Cap

The Clorox Company has a market capitalization of $11.38B.

Price: $94.14

4.51 (5.03%)

Market Cap: 11.38B

NYSE · time unavailable

CEO: Linda J. Rendle

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1983-03-21

Website: https://www.thecloroxcompany.com

The Clorox Company (CLX) - Company Information

Market Cap: 11.38B|Sector: Consumer Defensive

Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

Analyst Sentiment

45%
Hold

From 19 Active Polls

1Y Forecast: $105.50

▲ +12.1% Potential Upside

Consensus Target Metrics

Low Bound

$83

Median

$104

High Bound

$139

Average

$106

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$105.50
▲ +12.07% Upside
Low Target
$83.00
-12% Risk
Median Target
$103.50
10% Mid
High Target
$139.00
48% Max
Consensus
Hold
4 / 28 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)11,38412,57712,26115,12014,78918,16620,10120,16716,686
Enterprise Value ($M)14,68315,87615,25118,03217,50220,88422,90322,77319,387
Price to Earnings Ratio (P/E)15.1116.8119.5247.2511.1424.4226.0450.9319.31
Price/Earnings-to-Growth Ratio (PEG)1.140.583.94
Price to Sales Ratio (P/S)1.687.537.3310.587.4410.8911.9211.458.77
Price to Book Ratio (P/B)-170.52-187.71-98.09-687.2846.07672.81-490.26336.1250.87
Price to Free Cash Flow Ratio (P/FCF)29.96-76.2245.58265.2767.5377.96158.27110.8164.42
Enterprise Value to Sales (EV/Sales)9.519.1212.628.8012.5213.5812.9210.19
Enterprise Value to EBITDA (EV/EBITDA)11.2046.5651.7096.9535.7962.9073.4190.3754.61
Debt to Equity Ratio2.52-66.96-25.74-139.918.97109.04-75.4148.078.85

CLX Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$94.14
Intrinsic Value$82.80
Market Alignment
Overvalued by 12.0%relative to calculated intrinsic value
9.00%
Exp: 3%3%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$1.08B
Perpetuity TV Value$20.36B
Discounted TV (PV)$8.60B
TV Weighting %59.3%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CLOROX (CLX) — Investment Overview

🧩 Business Model Overview

Clorox operates as a consumer staples manufacturer and marketer with a focus on home care, cat litter, and water filtration. The business converts raw materials and packaging into branded, frequently purchased household products and distributes them through major retail and foodservice channels.

The value chain is rooted in (1) formulation and product development, (2) manufacturing and packaging efficiency, (3) category selling and shelf execution, and (4) retailer adoption supported by consistent demand and brand-led trial. Because these categories are consumables, the company’s economics depend heavily on maintaining share of shelf, protecting price/mix, and sustaining cost competitiveness.

💰 Revenue Streams & Monetisation Model

Monetisation is driven by transactional unit sales in consumable categories that translate into effectively repeat-purchase behavior. Margin performance typically depends on:

  • Volume vs. price/mix in household care and related categories.
  • Input and logistics costs (chemicals, packaging, freight) that can be partially offset through pricing, mix, and procurement scale.
  • Channel and promotion intensity, where disciplined trade spend can protect gross margin and reduce volatility.
  • Category-specific pricing dynamics: cat litter and disinfecting-related products can face periodic promotional cycles, while filtration products often reflect longer consideration/penetration cycles.

While revenue is not contractually recurring, the business exhibits structural consumption recurrence, which supports operating leverage when fixed costs are absorbed over stable production and distribution volumes.

🧠 Competitive Advantages & Market Positioning

Clorox’s moat is primarily rooted in scale/distribution leverage and private label resistance, supported by brand-linked category expertise and formulation know-how.

  • Scale/Distribution leverage: Large-scale manufacturing and procurement strengthen unit economics, while established relationships with major retailers improve availability, shelf placement, and planogram execution. Competitors without comparable scale often face higher per-unit costs and weaker retailer leverage.
  • Private label resistance: Many Clorox products sit in categories where performance expectations matter (especially in cleaning and disinfecting-linked uses). Competitors can undercut price, but matching outcomes and maintaining consumer acceptance is harder than in commoditized goods, limiting the speed and magnitude of private label displacement.
  • Formulation and category know-how: Product performance, safety, and regulatory-compliant manufacturing create incremental barriers in reformulation and technical validation for challengers.

Competitive benchmarking:

  • Procter & Gamble (P&G) — broader household portfolio with strong retailer penetration across detergents and cleaning adjacency, but with different category focus and product architecture.
  • Reckitt Benckiser — concentrated on disinfecting and hygiene; competes on specific efficacy claims and consumer trial, often with aggressive marketing intensity.
  • SC Johnson and/or Kimberly-Clark (adjacent home and household care competition) — competes via branded innovation and distribution relationships, with varying degrees of exposure to the specific home care subcategories Clorox leads.

Compared with these rivals, Clorox’s positioning is characterized by concentrated exposure to key household consumable categories where execution, product performance, and retailer shelf discipline play a larger role than broad portfolio breadth alone.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is more likely to come from share capture and category penetration than from expanding the market materially. Key drivers include:

  • Premiumization and mix: Uptrading within home care and filtration toward formats and use-cases with higher willingness to pay, supported by differentiation and performance.
  • Innovation with retailer-supported launches: Incremental SKU and format expansion that improves shelf productivity and deepens consumer routines.
  • Geographic and channel expansion where distribution gaps persist and where existing capabilities can be applied to new retail formats.
  • Operational productivity: Continuous improvement in manufacturing utilization, packaging optimization, and supply chain efficiency to sustain cost competitiveness through commodity cycles.
  • Regulatory and safety-led innovation: In categories where compliance and safety performance matter, firms with proven operational capability can maintain consumer trust and retailer confidence.

The principal TAM expansion is largely tied to household consumption of cleaning, pet care, and filtration and the conversion of consumers toward branded solutions when performance and dependability are valued.

⚠ Risk Factors to Monitor

  • Input cost and margin volatility: Chemicals, packaging, and freight costs can pressure gross margin if pricing power is insufficient.
  • Promotional intensity and retailer bargaining power: Increased trade spending can compress margins and weaken cash generation.
  • Category maturity and share shifts: Household care categories can be cyclical and sensitive to consumer trade-down, affecting volume durability.
  • Regulatory changes: Environmental and safety rules affecting ingredients, labeling, and disposal standards can require reformulation and compliance investment.
  • Operational execution risk: Manufacturing disruption, quality issues, or distribution failures can impair availability and drive avoidable share loss.
  • Currency and macro-driven demand: Consumer spending patterns can influence purchase frequency and pack-size selection.

📊 Valuation & Market View

The market typically values CLX and similar consumer staples companies on the durability of earnings and cash flow rather than on high-growth assumptions. Valuation frameworks often emphasize:

  • Cash flow conversion and margin resilience (ability to protect gross margin and control operating costs).
  • Earnings stability in down-cycles due to consumable demand characteristics.
  • Volume and mix sustainability as the primary determinant of forward earnings confidence.
  • Quality of brand-driven price/mix versus pure promotional leverage.

Investors generally adjust the valuation multiple when expectations diverge on margin trajectory, share stability, and the sustainability of productivity efforts.

🔍 Investment Takeaway

Clorox is best understood as a consumer staples compounder with structural support from consumable demand and a moat anchored in scale/distribution leverage and private label resistance in performance-sensitive home categories. The long-term thesis rests on disciplined execution—protecting shelf presence and mix, sustaining productivity against input volatility, and converting innovation into incremental share—while managing regulatory and promotional risks that can impair margin durability.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CLX.

seekingalpha.com2026-06-07

The Reasons Why I Believe A Buy Rating Is Not Justified For Clorox (Rating Upgrade)

Clorox managed to keep its sales flat YoY and improve its EPS slightly, despite contracting gross margins, due to elevated energy prices. Based on a dividend discount model, assuming 2% growth in perpetuity and a 7.7% required rate of return, the upside from the current price levels seems to be limited. For these reasons, I upgrade CLX to hold.

etftrends.com2026-06-06

Watch Out for Hidden Risks

Have you ever heard of Succession Risk? It occurs when key leaders of a company leave their position—whether expected or not—and a clear successor isn't already in place.

seekingalpha.com2026-06-03

The Clorox Company (CLX) Presents at 23rd annual dbAccess Global Consumer Conference Transcript

The Clorox Company (CLX) Presents at 23rd annual dbAccess Global Consumer Conference Transcript

prnewswire.com2026-06-02

Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges

Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute contact time and 40% less alcohol*, and Clorox Healthcare HyperOxi Disinfecting Wipes a bleach-free sporicidal wipe powered by Quanticare Technology that is easy to use and gentle on surfaces. Clorox Healthcare unveils an expanded healthcare portfolio designed to advance infection prevention with a quat alcohol-based daily disinfecting wipe and a bleach-free sporicidal disinfecting wipe.

fool.com2026-05-29

Best 3 Blue Chip Stocks to Buy After a Market Pullback -- Including Microsoft (MSFT) Stock

One of these stocks sports a dividend yield topping 5%.

fool.com2026-05-28

Kimberly-Clark vs. The Clorox: Which Consumer Goods Stock Is a Better Buy in 2026?

Compare two household staples as they navigate shifting profits, debt loads, and retailer influence, plus how their valuations stack up to the sector.

wsj.com2026-05-28

Clorox CEO to Step Down for Health Reasons

Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.

prnewswire.com2026-05-28

Clorox Board of Directors to Initiate Comprehensive CEO Search Process

Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO  OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons.

fool.com2026-05-28

Procter & Gamble vs. Clorox: Which Consumer Goods Stock Is a Better Buy in 2026?

Net margins, debt levels, and portfolio strategies set these two household giants apart. See how their fundamentals and valuations compare before you invest.

247wallst.com2026-05-27

5 Battered Blue-Chip Stocks That Pay Huge Dividends and Won't Be Down Forever

Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.

seekingalpha.com2026-05-21

Future Dividend Kings - Part 1

The first list of 8 companies that could reach Dividend King status in coming years. These companies provide investors a wide range of starting dividend yields and growth histories. It's possible one or more of these companies do not attain Dividend King status.

prnewswire.com2026-05-21

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company - CLX

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company ("Clorox" or the "Company") (NYSE: CLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

prnewswire.com2026-05-21

Glad® Features Sesame Street's Oscar the Grouch in new Limited-Edition Packaging

New collaboration brings a playful twist to everyday trash routines, turning a household chore into a moment of humor and personality. OAKLAND, Calif.

globenewswire.com2026-05-19

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company - CLX

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company (“Clorox” or the “Company”) (NYSE: CLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

247wallst.com2026-05-15

Don't Look Now, but 4 Blue-Chip Giants Could Be the Newest Dividend Kings

Companies that have raised dividends for shareholders for 50 years or more are the kinds of investments passive income investors need to own.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q3): Revenue $1.67B, Net Income $187M, EPS $1.54. YoY (vs 2025-03-31): Revenue +0.1% (1.668B to 1.670B) and Net Income +0.5% (186M to 187M). QoQ (vs 2025-12-31): Revenue -0.2% (1.673B to 1.670B) and Net Income +19.1% (157M to 187M). Profitability improved: net margin rose to ~11.2% from ~9.4% QoQ and ~11.2% vs ~11.2% YoY; gross margin was broadly stable (~43.2%). Cash flow quality weakened in the quarter: operating cash flow was -$122M and free cash flow was -$165M, turning down sharply from Q2’s strong OCF of $311M (QoQ). The quarter also showed heavy capital returns—$150M dividends paid and $256M share repurchases—while cash surged to $1.19B largely due to financing flows (other financing activities). Balance sheet resilience is mixed for a capital-intensive retailer: total assets increased to $6.44B, but equity remains very thin (about -$67M reported) with short-term debt elevated ($1.68B) and total debt $4.49B (net debt $3.30B). Shareholder returns are mixed—market price is down -23.6% over 1 year, partially offset by a ~1.2% dividend yield. Analyst targets (consensus ~$117) are below the current price (~$104.6), implying limited upside versus the Street’s base case, but the quarter’s EPS acceleration supports near-term confidence."

Revenue Growth

Neutral

Revenue was essentially flat YoY (+0.1%) and slightly down QoQ (-0.2%), indicating no clear top-line momentum.

Profitability

Positive

Net income rose QoQ (+19.1%) and net margin improved to ~11.2% from ~9.4% QoQ; YoY net income was roughly flat (+0.5%), suggesting better quarterly cost/tax/other items.

Cash Flow Quality

Caution

Operating cash flow was -$122M and free cash flow -$165M in the quarter, down from +$311M OCF in Q2; cash-flow volatility reduces earnings-to-cash confidence despite continued buybacks/dividends.

Leverage & Balance Sheet

Caution

Debt remains high (total debt ~$4.49B; net debt ~$3.30B). Reported equity is negative (-$67M), so balance-sheet resilience looks pressured even though interest coverage is strong (~17x).

Shareholder Returns

Caution

Capital returns were meaningful (dividends ~$150M; repurchases ~$256M). However, the stock’s 1-year price change is -23.6%, so total shareholder return momentum is currently weak; dividend yield is modest (~1.2%).

Analyst Sentiment & Valuation

Neutral

Consensus price target (~$117) is above the current price (~$104.6), suggesting some upside versus Street expectations, though dividend yield is not sufficient to offset valuation/momentum risk.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Clorox’s Q3 FY’26 call centered on an ERP-driven near-term disruption that slowed cost savings and margin, while category execution improved unevenly. Management reported clear strengths—Cleaning innovation led by Clorox PURE, sequential Glad distribution/share gains internationally, and Hidden Valley stabilizing via pack architecture and trend-forward launches (protein-forward and avocado oil), including reinstating the standard 16-ounce bottle. However, Litter/Fresh Step transformation is “bumpier” than expected, with remaining mapping and shelf-location issues at key retailers after the end-of-Q3 rollout, and Food faced a weaker category than expected due to high promotional intensity and deep discounting, pressuring dollars into mid-single-digit declines. Gross margin risk is amplified by Q4 oil assumptions (about $100/bbl) implying ~130 bps headwinds (~$20–$25m) before mitigation. Separately, GOJO’s April 1 close adds near-term dilution signals (50 bps year 1 gross margin dilution; 150 bps nonrepeating Q4 inventory step-up headwind) but remains strategically accretive with expected synergies and integration momentum.

AI IconGrowth Catalysts

  • Cleaning business strength; innovation execution “extraordinarily well,” including Clorox PURE allergen platform with preferred shelf placement and early distribution wins.
  • Glad: new absorbent layer trash bag, plus continued distribution progress and new scent; trash category up over 2 points and sequential share improving.
  • International: Glad sequentially improving quarter after quarter; distribution pick-up aided by price investment actions.
  • Hidden Valley: value/pack architecture work; returned standard 16-ounce bottle; trend-forward launches (protein-forward options, avocado oil item) driving share inflection.

Business Development

  • GOJO acquisition closed April 1 (integration underway; management team retained; integration partner retained).
  • Portfolio actions referenced: divestiture of Argentina; acquisition of majority ownership in the Saudi Arabia JV; sale of VMS; GOJO acquisition and expansion of Health and Hygiene portfolio.

AI IconFinancial Highlights

  • Q3 results “mixed,” falling short of expectations; gross margin below expectations due to higher-than-expected supply chain costs and delayed cost savings while stabilizing ERP.
  • Oil price assumption for Q4: ~$100/barrel midpoint; estimated 20–25m headwinds translating to ~130 bps gross margin impact; noted as full gross impact in Q4 with no mitigations yet deployed.
  • One-time transaction-related gross margin headwind in Q4: ~50 bps from onetime costs in gross margin that enables acceleration of more structural cost savings.
  • GOJO P&L impact: year 1 gross margin dilution ~50 bps; Q4 additional nonrepeating onetime inventory value step-up headwind ~150 bps in Q4.
  • GOJO financing/interest: run-rate pre-acquisition ~$100m; incremental interest expense ~$30m in Q4 and ~$110m next year.

AI IconCapital Funding

    AI IconStrategy & Ops

    • New ERP implementation: focused in first half on implementing and stabilizing; CEO noted ERP work created near-term disruption but is now complete.
    • Fresh Step / Litter reinvention: “complete reinvention” including changed items, names, claims, and price pack architecture; rollout began end of Q3; mapping consumers from former Fresh Step to new items is ongoing; shelf placement fixes underway at key retailers.
    • Shelf space execution: Q3 total distribution points up over 5%; retailers resetting shelves through remainder of Q4; management emphasized distribution gains but also detailed shelf-location remediation (Litter items placed next to unexpected SKUs).
    • RGM execution: management live in action; example given of price-down RGM work on glass at CAGNY to grow share; added market tests in coming weeks to expand into Q4 and fiscal 2027 plan.

    AI IconMarket Outlook

    • Remainder of 2026 category expectations: management expects categories to remain in ~0% to 1% aggregate range; cited market differences where March was slightly better than expected.
    • Category directional targets by segment: Litter closer to mid-single digits; Food down closer to mid-single digits; management expects some mitigation to help offset Food pressure.
    • Fiscal 2027 guidance timing: guidance expected in August (not provided in transcript).

    AI IconRisks & Headwinds

    • Litter: transformation “bumpier” than expected; distribution generally aligned but shelf placement on a couple items at key retailers not where expected; multiyear reinvention with innovation re-tracking risk.
    • Food / Hidden Valley: category weaker than expected; competitors driving high promotional intensity and deep discounting, pressuring dollars; consumer trend uncertainty referenced including GLP-1 related considerations.
    • Supply chain and margin: higher-than-expected supply chain costs and delayed cost savings due to ERP stabilization prioritized over earlier cost actions.
    • Oil and input cost uncertainty: assumes ~$100/barrel midpoint in Q4; management expects ability to cover input costs over time but near-term gross margin pressure is material.
    • Private label: shares flat overall; noted Brita as a category where private label showed ticks up during retailer promotions (monitoring risk).

    Q&A: Analyst Interest

    • Top-line trajectory: Why improvement didn’t match expectations, and how confidence was framed for fiscal ’27 across portfolio pieces. Management cited strength in Cleaning/International/Food share recovery but admitted Litter transformation progress slower, with shelf-placement fixes and Food category promotional pressure driving mid-single-digit declines versus expected low-single-digit.
    • Cost and inflation framing into ’27: analyst asked whether the majority of the $0.40 midpoint move is cost-related and how to view annualized headwinds. CFO said it’s too early for ’27 perspective; for Q4, $100/barrel assumption implies 20–25m ($130 bps) gross margin headwinds with no mitigation yet deployed.
    • GOJO acquisition mechanics: analyst asked whether oil-driven cost pressure changed GOJO guidance assumptions, including gross margin headwind magnitude. Management reiterated acquisition closed April 1, year 1 EBITDA neutral, ~$50m run-rate synergies, ~50 bps gross margin dilution in year 1, plus ~150 bps nonrepeating Q4 inventory step-up headwind; interest expense +$30m in Q4 and +$110m next year.

    Sentiment: MIXED

    Note: This summary was synthesized by AI from the CLX Q3 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    📋 Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for CLX.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    📁

    SEC Filings (CLX)

    © 2026 Stock Market Info — The Clorox Company (CLX) Financial Profile